Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring Exon21 L858R mutation: a multicenter retrospective obs... by Masashi Ishihara, Takahisa Kawamura, Yukiko Namba, Yuki Takeyasu, Yukihiro Hasegawa, Yuki Sato, Yoshiki Negi, Tomohiro Oba, Toshiyuki Sumi, Hirokuni Hirata, Hidemitsu Funabashi, Yuko Oya, Hajime Kikuchi, Naoko Katsurada, Takeshi Nakatani, Keiko Tanimura, Taku Nakagawa, Naoya Takeda, Takahiro Asami, Osamu Honjo, Hiromi Nagashima, Takumi Yamaura, Norihiko Hata, Miyako Kitazono, Naoya Nishioka, Akihiro Tamiya, Yuichi Sakamori, Ryota Shigaki, Kyoichi Kaira, Ryoichi Honda, Takashi Matsui, Eriko Suzuki, Kentaro Ito, Kojiro Otsuka, Naoto Takase, Yusuke Murakami, Kazuhiko Matsuno, Sumito Inoue, Akira Kisohara, Sojiro Kusumoto, Hiroe Aoshima, Yumiko Kakizaki, Akihito Kubo, Akito Hata, Nobuhisa Ishikawa, Kosuke Hamai, Nobuhiro Kanaji, Toshihiro Misumi, Noriyuki Matsutani, Nobuhiko Seki

Get full text

Independent association of a 17q21 variant with exacerbations in type 2–low adult asthma by Yumi Ishiyama, MD, Hisako Matsumoto, MD, PhD, Hironobu Sunadome, MD, PhD, Yuji Tohda, MD, PhD, Takahiko Horiguchi, MD, PhD, Hideo Kita, MD, PhD, Kazunobu Kuwabara, MD, PhD, Keisuke Tomii, MD, PhD, Kojiro Otsuka, MD, PhD, Masaki Fujimura, MD, PhD, Noriyuki Ohkura, MD, PhD, Katsuyuki Tomita, MD, PhD, Akihito Yokoyama, MD, PhD, Hiroshi Ohnishi, MD, PhD, Yasutaka Nakano, MD, PhD, Tetsuya Oguma, MD, PhD, Soichiro Hozawa, MD, PhD, Yoshihiro Kanemitsu, MD, PhD, Tadao Nagasaki, MD, PhD, Isao Ito, MD, PhD, Tsuyoshi Oguma, MD, PhD, Hideki Inoue, MD, PhD, Tomoko Tajiri, MD, PhD, Toshiyuki Iwata, MD, PhD, Junya Ono, BS, Shoichiro Ohta, MD, PhD, Tomomitsu Hirota, DOS, PhD, Mayumi Tamari, MD, PhD, Akio Niimi, MD, PhD, Kenji Izuhara, MD, PhD, Michiaki Mishima, MD, PhD, Toyohiro Hirai, MD, PhD

Get full text